Induction of hypoxia following radiofrequency ablation of liver tumors.

Completed

• Conditions: liver cancer; liver tumor; 10019815; 10019818

• Registration Number: NL-OMON36653
• Lead Sponsor: Vrije Universiteit Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 10

Inclusion Criteria

*Patients with liver tumor(s) treated with percutaneous RFA
*Age > 18 years
*Written informed consent

Exclusion Criteria

*Open RFA procedure for liver tumor by the surgeon
*Claustrophobia prohibiting PET-scanning

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary outcome measure: The endpoint of this study is the presence (or<br /><br>absence) of hypoxia (defined as demonstrable FAZA uptake) in the necrotic rim<br /><br>induced by RFA.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>not applicable</p><br>